Agilent Technologies Files 8-K Report

TL;DR

AGILENT filed an 8-K, likely routine updates, check for details.

AI Summary

On September 3, 2024, Agilent Technologies, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided text, suggesting it may be a routine filing or an update to previously disclosed information.

Why It Matters

This filing indicates Agilent Technologies is providing updates to the SEC, which could contain important information for investors regarding the company's operations or financial status.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification without specific material events or financial disclosures that would immediately indicate high risk.

Key Players & Entities

• AGILENT TECHNOLOGIES, INC. (company) — Registrant
• September 3, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 001-15405 (identifier) — Commission File Number
• 77-0518772 (identifier) — IRS Employer Identification No.
• 5301 Stevens Creek Boulevard (address) — Principal Executive Offices
• Santa Clara (location) — City of Principal Executive Offices
• CA (state) — State of Principal Executive Offices
• 95051 (zip_code) — Zip Code of Principal Executive Offices
• (800) 227-9770 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.01 — ANGE ON WHICH REGISTERED COMMON STOCK, $0.01 PAR VALUE A New York Stock Exchange I

Filing Documents

• a-20240903_d2.htm (8-K) — 39KB
• a-8kconsentxexx231.htm (EX-23.1) — 3KB
• a-20240903.htm (EX-99.1) — 2987KB
• 0001090872-24-000036.txt ( ) — 18707KB
• a-20240903.xsd (EX-101.SCH) — 82KB
• a-20240903_cal.xml (EX-101.CAL) — 86KB
• a-20240903_def.xml (EX-101.DEF) — 899KB
• a-20240903_lab.xml (EX-101.LAB) — 1286KB
• a-20240903_pre.xml (EX-101.PRE) — 1112KB
• a-20240903_d2_htm.xml (XML) — 3985KB

01. Other Events

Item 8.01. Other Events Agilent Technologies, Inc. (the "Company") is filing this Current Report on Form 8-K for the purpose of incorporating by reference the contents of this report in our filings under the Securities Act of 1933, as amended. Segment Reporting Changes As disclosed in the first quarter of fiscal year 2024, we announced a change in our operating segments to move our cell analysis business from our life sciences and applied markets segment to our diagnostics and genomics operating segment in order to further strengthen growth opportunities for both organizations. Following this reorganization, we continued to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continued to comprise a reportable segment. All historical financial segment information has been recast to conform to this new presentation in our subsequently filed consolidated financial statements and accompanying notes. There was no change to our Agilent CrossLab business segment. In Exhibit 99.1 to this Current Report on Form 8-K, we have recast the following items that were contained in our Annual Report on Form 10-K for the year ended October 31, 2023 ("Annual Report on Form 10-K"), to reflect the changes referenced above: Item 1, "Business," Item 2, "Properties," Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Item 8, "Financial Statements and Supplementary Data". This filing does not reflect any subsequent information or events occurring after we filed our Annual Report on Form 10-K other than adjustments to reflect the updated segment information in conjunction with the change in business structure described above and therein. The recast included in the exhibits to this Current Report on Form 8-K reflect changes to the Annual Report on Form 10-K as a result of the change in business structure. Without limitation of the foregoing, this fi

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following is filed as an exhibit to this report: Exhibit No. Description 23.1 Consent of Independent Registered Public Accounting Firm. 99.1 R ecast of certain Items for Agilent's Annual Report on Form 10-K for the year ended October 31, 2023. 104 Cover page interactive data file (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGILENT TECHNOLOGIES, INC. By: /s/ P. Diana Chiu Name: P. Diana Chiu Title: Vice President, Asst. General Counsel and Asst. Secretary Date: September 3, 2024 3

View Full Filing

View this 8-K filing on SEC EDGAR